2022
Jensen IS, Wu E, Cyr PL , Claussen M, Winkler T, Salahuddin K, Prats J, et al. 2022. Cost-consequence analysis of using cangrelor in high angiographic risk percutaneous coronary intervention patients: A US hospital perspective. Am J Cardiovasc Drugs 22(1):93-104; doi: 10.1007/s40256-021-00491-9 .
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Alexander AW, Jensen IJ, Hathaway J, Srivastava K, Cyr PL , Sidonio RF, Batt K. 2022. Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements. J Manag Care Spec Pharm 28(5):518-527; doi: 10.18553/jmcp.2022.21197 .
Topics: Health Economics and Outcomes Research (HEOR)
Sheshadri A, Sacks NC , Healey BE, Raza S, Boerner G, Huang HJ. 2022. Lung function monitoring after lung transplantation and allogeneic hematopoietic stem cell transplantation. Clin Ther 44(5):755–765.
View Abstract
Topics: Epidemiology , Health Economics and Outcomes Research (HEOR)
Sacks NC , Healey BE, Raza S, Cyr PL , Boerner G, Sheshadri A. 2022. The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States. Blood Adv 6(5):1566–1576; doi: 10.1182/bloodadvances.2021004364 .
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Sheshadri A, Sacks NC , Healey B, Cyr P , Boerner G, Huang HJ. 2022. The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States. J Med Econ 25(1):650–659; doi: 10.1080/13696998.2022.2071065 .
View Abstract
Topics: Health Economics and Outcomes Research (HEOR)
Cardosi L, Rau R, Emdem MR, Kemp R, Minshall M, Pontenani F, Provision S, Sacks N . 2022. Healthcare resource utilization in non-cystic fibrosis bronchiectasis (NCFB) patients with commercial insurance coverage in the US. Value in Health 25(12). Supplement. S1:S546.
View Abstract
Topics: Epidemiology
Soff GA, Ray-Coquard I, Rivera LJM, Fryzek J, Mullins M, Bylsma LC , Park JK. 2022. Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia. PLOS One 17(6):e0257673.
View Abstract
Topics: Epidemiology , Systematic Review
Leslie TF, Frankenfeld CL , Menon N. 2022. Disparities in colorectal cancer time-to-treatment and survival time associated with racial and economic residential segregation surrounding the diagnostic hospital, Georgia 2010–2015. Cancer Epidemiol 81:102267, https://doi.org/10.1016/j.canep.2022.102267 .
View Abstract
Topics: Epidemiology
Anneberg M, Svane HML, Fryzek J, Nicholson G, White JB, Edris B, Smith LM, Hooda N , Petersen MM, Baad-Hansen T, Keller JØ, Jørgensen PH, Pedersen AB. 2022. The epidemiology of desmoid tumors in Denmark. Cancer Epidemiol 77(April):102114; doi: 10.1016/j.canep.2022.102114 .
View Abstract
Topics: Epidemiology
2021
Mavunda K, Jiang X , Ambrose CS. 2021. Prevalence and clinical characteristics of perinatal chronic lung disease by infant gestational age. J Neonatal Perinatal Med 14(1):43–51, doi: 10.3233/NPM-200412.
View Abstract
A Division of